摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(5-nitro-pyridin-2-ylsulfanyl)-ethanol | 886585-55-3

中文名称
——
中文别名
——
英文名称
2-(5-nitro-pyridin-2-ylsulfanyl)-ethanol
英文别名
2-[(5-nitro-2-pyridinyl)thio]ethanol;2-(5-nitropyridin-2-yl)sulfanylethanol
2-(5-nitro-pyridin-2-ylsulfanyl)-ethanol化学式
CAS
886585-55-3
化学式
C7H8N2O3S
mdl
MFCD00067849
分子量
200.218
InChiKey
QRXFWNAZDAMHGI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    13
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.285
  • 拓扑面积:
    104
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
    申请人:Jones M. Robert
    公开号:US20060155128A1
    公开(公告)日:2006-07-13
    The present invention relates to certain substituted pyridinyl and pyrimidinyl derivatives of Fomula (Ia) that are modulators of metabolism. Accordingly, compounds of the present invention are useful in the treatment of metabolic-related disorders and complications thereof, such as, diabetes and obesity.
    本发明涉及某些取代的吡啶基和嘧啶基衍生物,其化学式为(Ia),这些衍生物是代谢调节剂。因此,本发明的化合物在治疗与代谢相关的疾病和并发症方面非常有用,如糖尿病和肥胖症。
  • Substituted pyridines and their uses
    申请人:Argade Ankush
    公开号:US20060178407A1
    公开(公告)日:2006-08-10
    The present invention is directed to substituted pyridines, methods for their preparation and methods for their use in the treatment and/or prevention of mast cell related conditions.
    本发明涉及取代吡啶、其制备方法以及在治疗和/或预防肥大细胞相关疾病方面使用的方法。
  • Substituted pyrindinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
    申请人:Jones M. Robert
    公开号:US20070078150A1
    公开(公告)日:2007-04-05
    The present invention relates to certain substituted pyridinyl and pyrimidinyl derivatives of Fomula (Ia) that are modulators of metabolism. Accordingly, compounds of the present invention are useful in the treatment of metabolic-related disorders and complications thereof, such as, diabetes and obesity.
    本发明涉及某些取代的吡啶基和嘧啶基衍生物,其化学式为(Ia),它们是代谢调节剂。因此,本发明的化合物在代谢相关疾病及其并发症的治疗中是有用的,例如糖尿病和肥胖症。
  • SUBSTITUTED PYRIDINYL AND PYRIMIDINYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE TREATMENT OF DISORDERS RELATED THERETO
    申请人:Arena Pharmaceuticals, Inc.
    公开号:EP1732562B1
    公开(公告)日:2007-12-19
  • SUBSTITUTED PYRIDINES WITH ACTIVITY ON SYK KINASE
    申请人:Rigel Pharmaceuticals, Inc.
    公开号:EP1817303A2
    公开(公告)日:2007-08-15
查看更多